FOUNDATIONS
Originator and generic medicines: start with the right question
A useful comparison starts with the approval pathway, reference product, quality standard and the regulator in the relevant market—not a blanket claim that one category is always better.
Separate terms before ranking products
An originator medicine commonly describes the product first developed and authorised for marketing. A generic medicine is authorised through a regulator-defined pathway when the relevant legal and scientific requirements are met. These labels are not a universal ranking of quality or suitability. The applicable approval basis, product availability and an individual's clinical situation are distinct questions.
Regulatory records are the shared language
Regulatory systems use different terms and procedures across markets. For a concrete product, begin with the local regulator's database and current product information. That is where readers can check a product's authorised status, dosage form, route, strength, holder and label version.
A practical verification sequence
Confirm the active ingredient, brand name if present, dosage form, route, strength and target market. Then read the applicable regulator's record and the current label. Questions about switching, dosage, contraindications or interactions belong with a physician or pharmacist who can assess the individual situation.
PRIMARY REFERENCE